Gastric Cancer
Conditions
Interventions
Interview group:No
Questionnaire team:No
Multiomics analysis group:No
Sponsors
Yangzhou Hospital of Traditional Chinese Medicine, Jiangsu Province
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-75 years old, gender unlimited; (2) Gastric cancer patients with definite pathological diagnosis. (3) Patients with gastric cancer stage IIIB-IV. (4) Those who meet the diagnostic criteria of TCM Syndromes of spleen deficiency, heat toxin syndrome, blood stasis and toxin accumulation syndrome, and phlegm toxin obstruction. (5) The estimated survival time is more than 3 months. (6) KPS score = 60 points. (7) Compliance is good, and informed consent must be signed before enrollment.
Exclusion criteria
Exclusion criteria: (1) Major trauma damage such as surgical treatment has occurred in the past month. (2) Those who have serious bleeding or systemic infection, are not controlled, or have purulent and chronic infection, and the wound does not heal. (3) At the same time, patients with hypersplenism, hyperthyroidism, connective tissue disease, tuberculosis and other diseases have not been controlled. (4) Patients with severe cardiovascular system complications, cerebrovascular system complications, active hepatitis, severe liver and kidney dysfunction. (5) Unable to understand, read and fill in the patient self-assessment scale due to knowledge level or intelligence. (6) Any unstable situation or situation that may endanger the safety of patients and their compliance with the study, such as schizophrenia and other serious mental diseases. (7) Other parts of the body are accompanied by or have had malignant tumors (except fully treated cervical carcinoma in situ, basal or squamous cell carcinoma of the skin, or other tumors that have been cured by surgery and have not recurred for at least 5 years). (8) Women of childbearing age with positive urine pregnancy test, lactation or insufficient contraception. (9) The researcher decided that he was not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| routine blood test;Metabonomics;Proteomics;Tumor markers;Genomics;Liver and kidney function;transcriptomics; | — |
Countries
China
Contacts
Public ContactDai Xiaojun
Yangzhou Hospital of Traditional Chinese Medicine, Jiangsu Province
Outcome results
None listed